July 10, 2026 · Form 4 insider transaction
Reed Kimberly A. sold 1,152 shares of Takeda Pharmaceutical Company Limited at $4931.20 per share, a transaction worth $5.68M. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4.
Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10.; The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,883 to JPY 5,045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.